Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1B Inhibition Promotes Megakaryocyte Polyploidization and Platelet Production

Abstract

Platelets are produced from mature megakaryocytes which undergo polyploidization and proplatelet formation. Cell-cycle regulation plays a crucial role in megakaryocyte terminal differentiation especially in polyploidization. Dual-specificity tyrosine phosphorylation-regulated kinase 1B (DYRK1B) controls cell-cycle progression in cancer cells. The objective of this study was to determine DYRK1B function in megakaryocyte maturation and platelet production. A DYRK1B knock-out mouse was generated with increased peripheral platelet count compared with the wild type mouse without affecting megakaryocyte numbers in bone marrow. Polyploidy and proplatelet formations were significantly enhanced when DYRK1B was depleted in vitro. DYRK1B inhibition promoted megakaryocyte maturation by simultaneously upregulating cyclin D1 and downregulating P27. Furthermore, there was platelet restoration in two mice disease models of transient thrombocytopenia. In summary, DYRK1B plays an important role in megakaryocyte maturation and platelet production by interacting with cyclin D1 and P27. DYRK1B inhibition has potential therapeutic value in transient thrombocytopenia treatment. [Graphic Abstract]

Keywords

platelet production - DYRK1B - cyclin D1 - P27

Data Sharing Statement

For original data, please contact [e-mail].

^* Contributed equally to this study.

Publikationsverlauf

Eingereicht: 17. Februar 2022

Angenommen: 17. September 2022

Accepted Manuscript online:
20. September 2022

Artikel online veröffentlicht:
28. Dezember 2022

• References

• 1 Noetzli LJ, French SL, Machlus KR. New insights into the differentiation of megakaryocytes from hematopoietic progenitors. Arterioscler Thromb Vasc Biol 2019; 39 (07) 1288-1300
• 2 Vainchenker W, Raslova H. Megakaryocyte polyploidization: role in platelet production. Platelets 2020; 31 (06) 707-716
• 3 Edgar BA, Zielke N, Gutierrez C. Endocycles: a recurrent evolutionary innovation for post-mitotic cell growth. Nat Rev Mol Cell Biol 2014; 15 (03) 197-210
• 4 Muntean AG, Pang L, Poncz M, Dowdy SF, Blobel GA, Crispino JD. Cyclin D-Cdk4 is regulated by GATA-1 and required for megakaryocyte growth and polyploidization. Blood 2007; 109 (12) 5199-5207
• 5 Bassini A, Pierpaoli S, Falcieri E. et al. Selective modulation of the cyclin B/CDK1 and cyclin D/CDK4 complexes during in vitro human megakaryocyte development. Br J Haematol 1999; 104 (04) 820-828
• 6 Matsumura I, Tanaka H, Kawasaki A. et al. Increased D-type cyclin expression together with decreased cdc2 activity confers megakaryocytic differentiation of a human thrombopoietin-dependent hematopoietic cell line. J Biol Chem 2000; 275 (08) 5553-5559
• 7 Eliades A, Papadantonakis N, Ravid K. New roles for cyclin E in megakaryocytic polyploidization. J Biol Chem 2010; 285 (24) 18909-18917
• 8 Geng Y, Yu Q, Sicinska E. et al. Cyclin E ablation in the mouse. Cell 2003; 114 (04) 431-443
• 9 Taniguchi T, Endo H, Chikatsu N. et al. Expression of p21(Cip1/Waf1/Sdi1) and p27(Kip1) cyclin-dependent kinase inhibitors during human hematopoiesis. Blood 1999; 93 (12) 4167-4178
• 10 Hu J, Nakhla H, Friedman E. Transient arrest in a quiescent state allows ovarian cancer cells to survive suboptimal growth conditions and is mediated by both Mirk/dyrk1b and p130/RB2. Int J Cancer 2011; 129 (02) 307-318
• 11 Jin K, Ewton DZ, Park S, Hu J, Friedman E. Mirk regulates the exit of colon cancer cells from quiescence. J Biol Chem 2009; 284 (34) 22916-22925
• 12 Becker W. Emerging role of DYRK family protein kinases as regulators of protein stability in cell cycle control. Cell Cycle 2012; 11 (18) 3389-3394
• 13 Friedman E. Mirk/dyrk1B kinase in ovarian cancer. Int J Mol Sci 2013; 14 (03) 5560-5575
• 14 Wang Z, Zhang Y, Kamen D, Lees E, Ravid K. Cyclin D3 is essential for megakaryocytopoiesis. Blood 1995; 86 (10) 3783-3788
• 15 Xu Y, Jiang H, Li L. et al. Branched-chain amino acid catabolism promotes thrombosis risk by enhancing tropomodulin-3 propionylation in platelets. Circulation 2020; 142 (01) 49-64
• 16 Zhao J, Xu Y, Xie J, Liu J, Zhang R, Yan X. Roxadustat does not affect platelet production, activation, and thrombosis formation. Arterioscler Thromb Vasc Biol 2021; 41 (10) 2523-2537
• 17 Jiang H, Yu Z, Ding N. et al. The role of AGK in thrombocytopoiesis and possible therapeutic strategies. Blood 2020; 136 (01) 119-129
• 18 Xiao M, Wang Y, Tao C. et al. Osteoblasts support megakaryopoiesis through production of interleukin-9. Blood 2017; 129 (24) 3196-3209
• 19 Nagahara H, Vocero-Akbani AM, Snyder EL. et al. Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med 1998; 4 (12) 1449-1452
• 20 Baccini V, Roy L, Vitrat N. et al. Role of p21(Cip1/Waf1) in cell-cycle exit of endomitotic megakaryocytes. Blood 2001; 98 (12) 3274-3282
• 21 Sun S, Zimmet JM, Toselli P, Thompson A, Jackson CW, Ravid K. Overexpression of cyclin D1 moderately increases ploidy in megakaryocytes. Haematologica 2001; 86 (01) 17-23
• 22 Wilhide CC, Van Dang C, Dipersio J, Kenedy AA, Bray PF. Overexpression of cyclin D1 in the Dami megakaryocytic cell line causes growth arrest. Blood 1995; 86 (01) 294-304
• 23 Zou Y, Ewton DZ, Deng X, Mercer SE, Friedman E. Mirk/dyrk1B kinase destabilizes cyclin D1 by phosphorylation at threonine 288. J Biol Chem 2004; 279 (26) 27790-27798
• 24 Ishida N, Kitagawa M, Hatakeyama S, Nakayama K. Phosphorylation at serine 10, a major phosphorylation site of p27(Kip1), increases its protein stability. J Biol Chem 2000; 275 (33) 25146-25154
• 25 Lambert MP, Gernsheimer TB. Clinical updates in adult immune thrombocytopenia. Blood 2017; 129 (21) 2829-2835
• 26 Zhang X, Chuai Y, Nie W, Wang A, Dai G. Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours. Cochrane Database Syst Rev 2017; 11: CD012035
• 27 Drachman JG, Sabath DF, Fox NE, Kaushansky K. Thrombopoietin signal transduction in purified murine megakaryocytes. Blood 1997; 89 (02) 483-492
• 28 Deng X, Mercer SE, Shah S, Ewton DZ, Friedman E. The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G(0) by Mirk/dyrk1B kinase. J Biol Chem 2004; 279 (21) 22498-22504
• 29 Quentmeier H, Zaborski M, Drexler HG. Effects of thrombopoietin, interleukin-3 and the kinase inhibitor K-252a on growth and polyploidization of the megakaryocytic cell line M-07e. Leukemia 1998; 12 (10) 1603-1611
• 30 Chu I, Sun J, Arnaout A. et al. p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. Cell 2007; 128 (02) 281-294
• 31 Xu X, Nakano T, Wick S, Dubay M, Brizuela L. Mechanism of Cdk2/Cyclin E inhibition by p27 and p27 phosphorylation. Biochemistry 1999; 38 (27) 8713-8722
• 32 Fero ML, Rivkin M, Tasch M. et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 1996; 85 (05) 733-744
• 33 Zimmet JM, Ladd D, Jackson CW, Stenberg PE, Ravid K. A role for cyclin D3 in the endomitotic cell cycle. Mol Cell Biol 1997; 17 (12) 7248-7259
• 34 Cruet-Hennequart S, Villalan S, Kaczmarczyk A, O'Meara E, Sokol AM, Carty MP. Characterization of the effects of cisplatin and carboplatin on cell cycle progression and DNA damage response activation in DNA polymerase eta-deficient human cells. Cell Cycle 2009; 8 (18) 3039-3050
• 35 Zeuner A, Signore M, Martinetti D, Bartucci M, Peschle C, De Maria R. Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor. Cancer Res 2007; 67 (10) 4767-4773
• 36 García P, Frampton J, Ballester A, Calés C. Ectopic expression of cyclin E allows non-endomitotic megakaryoblastic K562 cells to establish re-replication cycles. Oncogene 2000; 19 (14) 1820-1833
• 37 Jirawatnotai S, Hu Y, Michowski W. et al. A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. Nature 2011; 474 (7350): 230-234